Hemant Vaidya

Ph.D. Microbiology, Sardar Patel University, India
Post Doctoral Fellowship in Clinical Chemistry, Washington University School of Medicine, St. Louis MO

Research Expertise
Healthcare, In Vitro Diagnostics, product development, executive management, Healthcare Biotechnology

Hemant Vaidya, who has a Ph.D. in microbiology is a lecturer and director of the Biotechnology Industry Immersion program at the UC Davis Graduate School of Management. Until 2021 he taught Entrepreneurship Clinic at the same school. He is also an independent consultant in the In-Vitro Diagnostics (IVD) space and a Sacramento Angel investor.

Before the academic career, he worked in the IVD industry for 24 years. During the last 14 years of his industry career, he was vice president of R&D for Siemens Microbiology (and Molecular) diagnostics business unit. In that role, he was responsible for assessing new ideas and technologies and for planning product development from concept to commercialization. The role also included creating the annual operating plan, strategy, and a technology road map.

During his clinical chemistry post-doctoral training at Washington University School of Medicine in St. Louis, MO, he developed the first monoclonal antibody for creatine kinase MB, a biochemical marker for myocardial infarction (heart attack), which was patented and widely licensed in the IVD industry. He has mentored several entrepreneurs in the U.S. He also mentors entrepreneurs in India through a program at the Indian Institute of Management, Ahmedabad." He has authored (or co-authored) four patents and 24 publications.